Petrina Kamya, PhD, Head of AI Platforms at Insilico Medicine (IMAGE)
Caption
Dr. Kamya is President of Insilico Medicine Canada and will lead the collaboration with University of Toronto, in which researchers will test small molecules designed with Insilico's generative AI platform against 15-20 undruggable targets using Dr. Stagljar's live cell assays.
Credit
Insilico Medicine
Usage Restrictions
none
License
Original content